Skip to main content
Dysmetabolic Diseases on Muck Rack

Dysmetabolic Diseases

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Dysmetabolic

Contact Dysmetabolic, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Two drugs are better than one to start T2DM therapy

|
By Francesco Prattichizzo, Lucia La Sala, Antonio Ceriello, Dysmetabolic Diseases
| Nature Verified
Early and intensive glycaemic control protects patients with type 2 diabetes mellitus (T2DM) from the development of late cardiovascular complications. The authors of the VERIFY trial now show that a more durable attainment of HbA1c <7% is observed by adding vildagliptin to metformin as starting therapy in newly diagnosed patients with T2DM. Fig. 1: Proposal for merging the glucocentric and the cardiocentric view of T2DM treatment. References 1.
Open in Who Shared Issue with article?

A unique plasma microRNA profile defines type 2 diabetes progression

|
By Paola de Candia, Gaia Spinetti, Dysmetabolic Diseases, Claudia Specchia
| PLOS
A major unmet medical need to better manage Type 2 Diabetes (T2D) is the accurate disease prediction in subjects who show glucose dysmetabolism, but are not yet diagnosed as diabetic.
Open in Who Shared Issue with article?
See all 2 articles